House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Gastroenterology

Pancreatitis: Acute

ACG · 2024 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

ACG acute pancreatitis guidance prioritises confirming the diagnosis, establishing the cause, recognising evolving organ failure and providing early supportive care. Fluid treatment, feeding and intervention decisions depend on the patient's clinical state. This focused summary preserves the distinction between uncomplicated biliary pancreatitis and cholangitis, between sterile and infected necrosis, and between stable patients suitable for delayed intervention and those who deteriorate.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Confirm pancreatitis and look for its cause

  • Diagnose acute pancreatitis when at least 2 of 3 features are present: characteristic abdominal pain, amylase/lipase above 3 times the upper limit of normal, or characteristic imaging. Lipase is preferred to amylase; enzyme elevation must be interpreted with the clinical picture. [1]
  • Do not obtain routine admission CT solely to grade severity. Reserve CT for uncertain diagnosis or failure to improve within 48–72 hours after admission and hydration; in non-improvement, CT or MRI can assess complications. [1]
  • Once acute pancreatitis is established, serial amylase or lipase is not useful for judging severity, feeding or discharge readiness. Follow the patient's clinical course rather than waiting for enzyme normalisation. [1]
  • Conditionally use transabdominal ultrasound to assess a biliary cause and repeat it when inconclusive. For unexplained pancreatitis, conditionally pursue repeat ultrasound, MRI and/or endoscopic ultrasound; both recommendations have very-low-quality evidence. [1]
  • If gallstones and significant alcohol exposure do not explain the episode, obtain triglycerides; a level above 1,000 mg/dL favours that aetiology. In patients older than 40 with no established cause, consider a pancreatic tumour, especially with a prolonged or recurrent course. [1]
  • After a second unexplained episode, the guideline suggests cholecystectomy in a patient fit for surgery to reduce recurrence. True recurrent idiopathic pancreatitis warrants assessment at a pancreatic-disease centre with advanced diagnostic and multidisciplinary expertise. [1]

Monitor closely and individualise fluid therapy

  • Assess haemodynamics and clinical risk to choose the appropriate monitored setting. Prefer a monitored bed for organ failure or SIRS; remain vigilant for deterioration during the first 48 hours even if disease initially appears mild. Scores or imaging alone cannot reliably predict the course. [1]
  • ACG conditionally suggests moderately aggressive crystalloid resuscitation, adding boluses for evidence of hypovolaemia, and favours lactated Ringer over normal saline; evidence quality is low. Caution and volume-overload monitoring are essential with cardiac or renal comorbidity. [1]
  • Fluid treatment matters most early. Reassess volumes within 6 hours and frequently over the next 24–48 hours, using clinical perfusion, urine output and laboratory trends including BUN. Avoid carrying an aggressive fluid strategy forward automatically when severe disease or overload develops. [1]

Select ERCP for the right indication

  • For acute biliary pancreatitis without cholangitis, ACG conditionally favours medical care over early ERCP within 72 hours, with low-quality evidence. When pancreatitis is complicated by cholangitis, arrange early ERCP within 24 hours. [1]
  • In the absence of cholangitis or jaundice, investigate a suspected common-bile-duct stone with MRCP or endoscopic ultrasound before considering ERCP. Avoid purely diagnostic ERCP because it introduces pancreatitis risk. [1]
  • For patients at high risk of post-ERCP pancreatitis, recommend rectal indomethacin unless contraindicated; the guideline has strong, moderate-quality support. The narrative describes a single 100 mg dose before or immediately after ERCP. [1]
  • In high-risk ERCP patients receiving rectal indomethacin, conditionally consider a pancreatic-duct stent as additional prevention; evidence quality is low. Use a case-by-case expert approach because stenting may be technically difficult and failed placement carries risk. [1]

Distinguish infection from sterile inflammation

  • ACG conditionally suggests against prophylactic antibiotics in severe pancreatitis, with very-low-quality evidence. Do not treat sterile pancreatic necrosis with antibiotics solely because necrosis is present; infected necrosis is a different indication. [1]
  • For suspected infection, give antibiotics while confirming its source. If cultures are negative and no infectious source is found, discontinue them. Routine antifungal medication alongside prophylactic or therapeutic antibiotics is unnecessary. [1]
  • ACG conditionally suggests against routine fine-needle aspiration for suspected infected pancreatic necrosis, with very-low-quality evidence. Clinical infection assessment and other evidence can guide treatment without making aspiration a mandatory prerequisite. [1]
  • For clinically stable infected necrosis, use antibiotics with pancreatic-necrosis penetration to allow delayed drainage or debridement, ideally beyond 4 weeks; some patients recover without drainage. Deterioration or lack of a prompt response requires intervention assessment instead of waiting for that interval. [1]

Restore feeding according to tolerance

  • In mild pancreatitis, conditionally start oral feeding within 24–48 hours as tolerated, using a low-fat solid diet rather than obligatory clear-liquid progression. Both recommendations have low-quality evidence; significant nausea, vomiting or ileus argues against forcing early oral intake. [1]
  • Use enteral nutrition in moderately severe or severe pancreatitis. Avoid parenteral nutrition unless enteral delivery is impossible, not tolerated or insufficient for calorie needs. [1]
  • Nasogastric tube feeding is generally preferred over nasojejunal delivery because safety/efficacy are comparable and placement is easier. Use aspiration precautions and an upright position; continuous tube-feed infusion is preferred over bolus or cyclic delivery. [1]

Prevent recurrence and time intervention

  • For mild acute biliary pancreatitis, perform cholecystectomy early, preferably before discharge. Pancreatic necrosis complicating biliary pancreatitis requires a different multidisciplinary timing decision rather than automatic application of the mild-disease pathway. [1]
  • For stable patients with pancreatic necrosis, delay intervention preferably 4 weeks to let the collection wall mature. If symptomatic necrosis needs debridement, favour minimally invasive techniques over open surgery and refer to an experienced multidisciplinary centre. [1]

Limitations and use

  • The fluid approach requires repeated bedside assessment rather than a fixed volume for every patient. Cardiac/renal disease, severe pancreatitis and volume overload change the balance of benefit and harm.
  • This is not a complete ICU, antimicrobial-selection or drainage protocol. The preferred delay for necrosis applies to clinically stable patients and must not postpone assessment of deterioration or uncontrolled infection.
  • Specialist procedure availability, antimicrobial resistance, comorbidities and drug contraindications require local adaptation in India. Paediatric-specific management and detailed pregnancy pathways are outside this summary.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Pancreatitis: Acute

    Selected recommendation material consulted

Original guideline

Publication details

Issuing organisation
ACG
Resource type
Clinical guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Confirm pancreatitis and look for its cause
  • Monitor closely and individualise fluid therapy
  • Select ERCP for the right indication
  • Distinguish infection from sterile inflammation
  • Restore feeding according to tolerance
  • Prevent recurrence and time intervention
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House